» Articles » PMID: 35795702

Wearable Walking Assistant for Freezing of Gait With Environmental IoT Monitoring: A Contribution to the Discussion

Overview
Specialty Public Health
Date 2022 Jul 7
PMID 35795702
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, significantly increasing in the last three decades. Worldwide, seven to ten million people are affected by PD. In people living with PD, freezing of gait (FoG) significantly impacts activities of daily living, potentially leading to falls, injuries, and loss of autonomy. FoG prevalence rates vary widely, reaching at least 50% of patients with PD. Current therapeutic options have limited effectiveness, and their complement with innovative technology-based solutions in the real world is demanded to enhance daily functioning for people living with PD. This article provides a narrative review of current technological developments for people living with PD and, derived from that evidence, presents a perspective on integrating wearable technology and IoT to support telemonitoring and self-management of people living with PD in their daily living environment. Complementing current therapeutic options with technology-based solutions in PD patients' real-world environment is crucial to enhancing the quality of life of people living with PD. In that way, wearable technology and IoT might constitute resources of excellence in seamless monitoring and self-management in people's home environments.

Citing Articles

Gait Characteristics Analyzed with Smartphone IMU Sensors in Subjects with Parkinsonism under the Conditions of "Dry" Immersion.

Meigal A, Gerasimova-Meigal L, Reginya S, Soloviev A, Moschevikin A Sensors (Basel). 2022; 22(20).

PMID: 36298272 PMC: 9611186. DOI: 10.3390/s22207915.

References
1.
Berganzo K, Tijero B, Gonzalez-Eizaguirre A, Somme J, Lezcano E, Gabilondo I . Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups. Neurologia. 2014; 31(9):585-591. DOI: 10.1016/j.nrl.2014.10.010. View

2.
Tibar H, Bayad K, Bouhouche A, Haddou E, Benomar A, Yahyaoui M . Non-Motor Symptoms of Parkinson's Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients. Front Neurol. 2018; 9:170. PMC: 5893866. DOI: 10.3389/fneur.2018.00170. View

3.
Yang W, Hamilton J, Kopil C, Beck J, Tanner C, Albin R . Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Parkinsons Dis. 2020; 6:15. PMC: 7347582. DOI: 10.1038/s41531-020-0117-1. View

4.
Maetzler W, Klucken J, Horne M . A clinical view on the development of technology-based tools in managing Parkinson's disease. Mov Disord. 2016; 31(9):1263-71. DOI: 10.1002/mds.26673. View

5.
Muthukrishnan N, Abbas J, Shill H, Krishnamurthi N . Cueing Paradigms to Improve Gait and Posture in Parkinson's Disease: A Narrative Review. Sensors (Basel). 2019; 19(24). PMC: 6960538. DOI: 10.3390/s19245468. View